Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy

Hye Na Jung, Sung Mok Kim, Jeong Hyun Lee, Yiseul Kim, Sang Chol Lee, Eun Seok Jeon, Hwan Seok Yong, Yeon Hyeon Choe

Research output: Contribution to journalArticle

Abstract

Background: Administration of gadolinium-contrast can cause problems in cardiac amyloidosis (CA) patients with impaired renal function. Purpose: To compare patterns of cardiovascular magnetic resonance tissue tracking (CMR-TT) for CA and hypertrophic cardiomyopathy (HCM) and to assess the feasibility of CMR-TT to distinguish between these diseases without administration of gadolinium-contrast. Material and Methods: Included were 54 patients with biopsy-proven CA, 40 patients with HCM, and 30 healthy people. We calculated strain ratio of apex to base (SRAB) in the left ventricle (LV) using radial (R), circumferential (C), and longitudinal (L) strain from CMR-TT. The LV ejection fraction (LVEF) and the ratio of septal to posterior wall at basal level were also calculated. Late gadolinium enhancement (LGE) image analysis was performed for differential diagnosis. Area under the receiver operating characteristic curve (AUC) comparisons were used. Results: All SRAB values were significantly different between CA and HCM (all P < 0.001). AUC values for parameters were 0.806 for LVEF, 0.815 for ratio of wall thickness, 0.944 for the LGE pattern, 0.898 for SRABR, 0.880 for SRABC, and 0.805 for SRABL. AUCs for the LGE pattern were significantly higher than for LVEF, ratio of wall thickness and SRABL (all P < 0.008). No significant differences were seen between AUCs for the LGE pattern, SRABR, and SRABC (all P > 0.109). Conclusion: SRABR and SRABC were reliable parameters for distinguishing between CA and HCM.

Original languageEnglish
JournalActa Radiologica
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

Hypertrophic Cardiomyopathy
Amyloidosis
Magnetic Resonance Spectroscopy
Gadolinium
Heart Ventricles
Image Enhancement
ROC Curve
Area Under Curve
Differential Diagnosis
Kidney
Biopsy

Keywords

  • cardiac amyloidosis
  • cardiovascular magnetic resonance
  • hypertrophic cardiomyopathy
  • myocardial strain
  • strain
  • Tissue tracking

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy. / Jung, Hye Na; Kim, Sung Mok; Lee, Jeong Hyun; Kim, Yiseul; Lee, Sang Chol; Jeon, Eun Seok; Yong, Hwan Seok; Choe, Yeon Hyeon.

In: Acta Radiologica, 01.01.2019.

Research output: Contribution to journalArticle

Jung, Hye Na ; Kim, Sung Mok ; Lee, Jeong Hyun ; Kim, Yiseul ; Lee, Sang Chol ; Jeon, Eun Seok ; Yong, Hwan Seok ; Choe, Yeon Hyeon. / Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy. In: Acta Radiologica. 2019.
@article{acb016030afe435b8c0cf7c14bb3608a,
title = "Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy",
abstract = "Background: Administration of gadolinium-contrast can cause problems in cardiac amyloidosis (CA) patients with impaired renal function. Purpose: To compare patterns of cardiovascular magnetic resonance tissue tracking (CMR-TT) for CA and hypertrophic cardiomyopathy (HCM) and to assess the feasibility of CMR-TT to distinguish between these diseases without administration of gadolinium-contrast. Material and Methods: Included were 54 patients with biopsy-proven CA, 40 patients with HCM, and 30 healthy people. We calculated strain ratio of apex to base (SRAB) in the left ventricle (LV) using radial (R), circumferential (C), and longitudinal (L) strain from CMR-TT. The LV ejection fraction (LVEF) and the ratio of septal to posterior wall at basal level were also calculated. Late gadolinium enhancement (LGE) image analysis was performed for differential diagnosis. Area under the receiver operating characteristic curve (AUC) comparisons were used. Results: All SRAB values were significantly different between CA and HCM (all P < 0.001). AUC values for parameters were 0.806 for LVEF, 0.815 for ratio of wall thickness, 0.944 for the LGE pattern, 0.898 for SRABR, 0.880 for SRABC, and 0.805 for SRABL. AUCs for the LGE pattern were significantly higher than for LVEF, ratio of wall thickness and SRABL (all P < 0.008). No significant differences were seen between AUCs for the LGE pattern, SRABR, and SRABC (all P > 0.109). Conclusion: SRABR and SRABC were reliable parameters for distinguishing between CA and HCM.",
keywords = "cardiac amyloidosis, cardiovascular magnetic resonance, hypertrophic cardiomyopathy, myocardial strain, strain, Tissue tracking",
author = "Jung, {Hye Na} and Kim, {Sung Mok} and Lee, {Jeong Hyun} and Yiseul Kim and Lee, {Sang Chol} and Jeon, {Eun Seok} and Yong, {Hwan Seok} and Choe, {Yeon Hyeon}",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/0284185119883714",
language = "English",
journal = "Acta Radiologica",
issn = "0284-1851",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy

AU - Jung, Hye Na

AU - Kim, Sung Mok

AU - Lee, Jeong Hyun

AU - Kim, Yiseul

AU - Lee, Sang Chol

AU - Jeon, Eun Seok

AU - Yong, Hwan Seok

AU - Choe, Yeon Hyeon

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Administration of gadolinium-contrast can cause problems in cardiac amyloidosis (CA) patients with impaired renal function. Purpose: To compare patterns of cardiovascular magnetic resonance tissue tracking (CMR-TT) for CA and hypertrophic cardiomyopathy (HCM) and to assess the feasibility of CMR-TT to distinguish between these diseases without administration of gadolinium-contrast. Material and Methods: Included were 54 patients with biopsy-proven CA, 40 patients with HCM, and 30 healthy people. We calculated strain ratio of apex to base (SRAB) in the left ventricle (LV) using radial (R), circumferential (C), and longitudinal (L) strain from CMR-TT. The LV ejection fraction (LVEF) and the ratio of septal to posterior wall at basal level were also calculated. Late gadolinium enhancement (LGE) image analysis was performed for differential diagnosis. Area under the receiver operating characteristic curve (AUC) comparisons were used. Results: All SRAB values were significantly different between CA and HCM (all P < 0.001). AUC values for parameters were 0.806 for LVEF, 0.815 for ratio of wall thickness, 0.944 for the LGE pattern, 0.898 for SRABR, 0.880 for SRABC, and 0.805 for SRABL. AUCs for the LGE pattern were significantly higher than for LVEF, ratio of wall thickness and SRABL (all P < 0.008). No significant differences were seen between AUCs for the LGE pattern, SRABR, and SRABC (all P > 0.109). Conclusion: SRABR and SRABC were reliable parameters for distinguishing between CA and HCM.

AB - Background: Administration of gadolinium-contrast can cause problems in cardiac amyloidosis (CA) patients with impaired renal function. Purpose: To compare patterns of cardiovascular magnetic resonance tissue tracking (CMR-TT) for CA and hypertrophic cardiomyopathy (HCM) and to assess the feasibility of CMR-TT to distinguish between these diseases without administration of gadolinium-contrast. Material and Methods: Included were 54 patients with biopsy-proven CA, 40 patients with HCM, and 30 healthy people. We calculated strain ratio of apex to base (SRAB) in the left ventricle (LV) using radial (R), circumferential (C), and longitudinal (L) strain from CMR-TT. The LV ejection fraction (LVEF) and the ratio of septal to posterior wall at basal level were also calculated. Late gadolinium enhancement (LGE) image analysis was performed for differential diagnosis. Area under the receiver operating characteristic curve (AUC) comparisons were used. Results: All SRAB values were significantly different between CA and HCM (all P < 0.001). AUC values for parameters were 0.806 for LVEF, 0.815 for ratio of wall thickness, 0.944 for the LGE pattern, 0.898 for SRABR, 0.880 for SRABC, and 0.805 for SRABL. AUCs for the LGE pattern were significantly higher than for LVEF, ratio of wall thickness and SRABL (all P < 0.008). No significant differences were seen between AUCs for the LGE pattern, SRABR, and SRABC (all P > 0.109). Conclusion: SRABR and SRABC were reliable parameters for distinguishing between CA and HCM.

KW - cardiac amyloidosis

KW - cardiovascular magnetic resonance

KW - hypertrophic cardiomyopathy

KW - myocardial strain

KW - strain

KW - Tissue tracking

UR - http://www.scopus.com/inward/record.url?scp=85074824097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074824097&partnerID=8YFLogxK

U2 - 10.1177/0284185119883714

DO - 10.1177/0284185119883714

M3 - Article

C2 - 31684748

AN - SCOPUS:85074824097

JO - Acta Radiologica

JF - Acta Radiologica

SN - 0284-1851

ER -